← Leaderboards
Peter C Dowling
Va New Jersey Health Care System
$0
Attributed
$0
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2009–21$1$1$1$0$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
VA$0 · 3
By mechanism
I01$0 · 2
I21$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Va New Jersey Health Care System
Same institution · by research overlap
- Yun-Beom Choi$872,510
- Yasuhiro Maeda$0
- Kevin D. Beck$1,201,019
- Bruce A. Citron$0
- Ambrose Arthur Dunn-Meynell$0
Others in their field
Top investigators on “Peptides”
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- John M Lachin · George Washington University$118,672,444
- David Heimbrook · Leidos Biomedical Research, Inc.$91,429,616
- Michael W Weiner · Northern California Institute Res &Educ$78,425,041
- Paul S. Aisen · Cognition Therapeutics, Inc.$69,846,203
- Rolf Apweiler · European Molecular Biology Laboratory$56,677,991
Research focus
PeptidesImmuneResponseInflammatoryVeteransImmunohistochemistryBioluminescenceLuciferasesGlial Fibrillary Acidic ProteinBrainEffective TherapyTherapeutic EffectAnimalsMediatingHealthcareTransgenesNeurobehavioralPathologyNeuronsAdverse EffectsMouse ModelAnimal ModelNerve DegenerationNeurodegenerative Disorders
Grant awards (11)
Treatment of chronic traumatic encephalopathy in a mouse model with a side effect free erythropoietin derived immune modulator.$0
I21 · FY2021 · VA · contact PI
Treatment of chronic traumatic encephalopathy in a mouse model with a side effect free erythropoietin derived immune modulator.$0
I21 · FY2019 · VA · contact PI
Novel EPO peptide therapy for a new mouse model of dementia$0
I01 · FY2019 · VA · contact PI
Novel EPO peptide therapy for a new mouse model of dementia$0
I01 · FY2017 · VA · contact PI
Novel EPO peptide therapy for a new mouse model of dementia$0
I01 · FY2017 · VA · contact PI
Novel EPO peptide therapy for a new mouse model of dementia$0
I01 · FY2016 · VA · contact PI
New generation EPO peptides with enhanced safety for acute TBI$0
I01 · FY2015 · VA · contact PI
New generation EPO peptides with enhanced safety for acute TBI$0
I01 · FY2015 · VA · contact PI
Novel EPO peptide therapy for a new mouse model of dementia$0
I01 · FY2015 · VA · contact PI
New generation EPO peptides with enhanced safety for acute TBI$0
I01 · FY2015 · VA · contact PI
New generation EPO peptides with enhanced safety for acute TBI$0
I01 · FY2009 · VA · contact PI